On March 23, 2026, Intensity Therapeutics, Inc. announced the filing of a prospectus supplement to increase the capacity of its existing 'at-the-market' (ATM) offering program to $60 million. This strategic move is aimed at enhancing the company's financial flexibility, allowing it to access capital efficiently when deemed appropriate. The company clarified that while the ATM program has been expanded, it is under no obligation to issue any shares under this program. The decision to utilize the ATM will depend on market conditions and the company's strategic priorities. The ATM offering is conducted under an agreement with H.C. Wainwright & Co. LLC, which serves as the sales agent. The increase in capacity reflects the company's ongoing efforts to strengthen its financial position and support its operational needs. Investors and stakeholders will be closely monitoring how this decision impacts the company's stock performance and overall market perception.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.